S. 4333 117th Congress Senate

CLEAR Act

Official title: A bill to deem certain products regulated by the Food and Drug Administration as drugs.

Introduced: May 26, 2022 Introduced by: Tina Smith Democratic · Minnesota See on congress.gov

Health

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

May 26, 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

May 26, 2022

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Latest action May 26, 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Plain-English summary Congressional Research Service

Consistent Legal Evaluation And Regulation of Medical Products Act or the CLEAR Act

This bill requires the Food and Drug Administration to regulate contrast agents for medical imaging devices, radioactive drugs, over-the-counter monograph drugs, and ophthalmic drug articles (i.e., eye droppers) as drugs rather than medical devices.

Related & companion bills 1

Bill text 1 version